Strep Assay Delivers Results in One Hour
The FDA-cleared Lyra Direct Strep Assay kit from Quidel differentiates between pyogenic Group A and pyogenic C or G Streptococcal throat infections.
Read MorePosted by Jenny Lower | Apr 28, 2014 | Infectious Diseases |
The FDA-cleared Lyra Direct Strep Assay kit from Quidel differentiates between pyogenic Group A and pyogenic C or G Streptococcal throat infections.
Read MorePosted by Jenny Lower | Apr 17, 2014 | Cancer |
Menssana Research laboratories have established a new role for breath testing in the early detection of disease. Scientists there have developed a portable breath collection apparatus that can collect breath samples for highly sensitive laboratory analysis virtually anywhere.
Read MorePosted by Jenny Lower | Apr 17, 2014 | Emerging & Zoonotic Diseases, Infectious Diseases, POC Instruments, POC Rapid Assays, Sexually Transmitted Diseases |
Headquartered in Halifax, Nova Scotia, Canada, MedMira is developing a robust pipeline of tests based on its patented Rapid Vertical Flow technology. The technology facilitates the formation of highly specific antigen-antibody reactions, allowing specific biomarkers in many sample types—including human whole blood, serum, or plasma—to be captured and visualized on a unique membrane.
Read MorePosted by Jenny Lower | Apr 17, 2014 | Cancer |
Technologies rarely advance at a steady and predictable pace, but new platforms and newer ideas are already shaping the future of clinical lab testing. This article from the April 2014 issue highlights a handful of companies that are working to bring new diagnostic technologies to market and improve patient care.
Read MorePosted by Steve Halasey | Apr 11, 2014 | Cancer |
CDC’s grant of more than $1.25 million to the College of American Pathologists will help laboratory professionals improve the delivery of patient testing guidelines and cancer reporting.
Read More